FDA Clearance Tracker · P010047-S036
PROGEL PLEURAL AIR LEAK SEALANT
Last checked: Nov 20, 2026Latest source record: Feb 13, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Feb 13, 2015
Approved
Time to decision
217 days
Received Jul 11, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P010047-S036
- Device name
- PROGEL PLEURAL AIR LEAK SEALANT
- Applicant
- Neomend, Inc.
- Applicant location
- Irvine, CA
- Received
- Jul 11, 2014
- Decided
- Feb 13, 2015
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P010047
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE PROGEL PLEURAL AIR LEAK SEALANT (PALS). THE SINGLE USE PROGEL PLEURAL AIR LEAK SEALANT DEVICE IS INDICATED FOR APPLICATION TO VISCERAL PLEURA AFTER STANDARD VISCERAL PLEURAL CLOSURE WITH, FOR EXAMPLE, SUTURES OR STAPLES, OF VISIBLE AIR LEAKS INCURRED DURING RESECTION OF LUNG PARENCHYMA.
Source documents
Other decisions for Neomend, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P150016 · Decided Apr 11, 2016 · 350 days after receipt
Device type: Sealant, polymerizing (NBE) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.